Advancements in Anticoagulants: A Focus on Rivaroxaban

Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements. Thank you for your cooperation and commitment to professional development. Participation in this training is entirely voluntary, and you are free to opt out at any time. Please be assured that no personal information of any healthcare professional (HCP) will be shared with Tridem Pharma. Your privacy and confidentiality remain fully protected.

This virtual Continuing Professional Development (CPD) training will provide healthcare professionals with a comprehensive update on the latest advancements in anticoagulant therapy, particularly focusing on Rivaroxaban. The session will delve into its evolving role in clinical practice, supported by recent research findings and practical insights for optimizing patient care. Through this webinar, participants will gain valuable knowledge from expert local and international resource persons in the field.

WHY YOU SHOULD ATTEND

This event is designed for healthcare professionals involved in managing patients with thromboembolic disorders. Attendees will gain an in-depth understanding of Rivaroxaban’s role in the treatment of atrial fibrillation, pulmonary embolism, and its use in surgical prophylaxis. The session will equip you with up-to-date evidence on the pharmacology of Rivaroxaban, its clinical applications, and emerging trends in anticoagulant therapy. As healthcare providers, staying abreast of the latest advancements in treatment is crucial for delivering optimal care to patients. This event is an excellent opportunity to update your knowledge and participate in dynamic discussions led by renowned experts.

EVENT HIGHLIGHTS

1. Fosun/Tridem Product Presentation: Gain insight into the pharmaceutical products related to Rivaroxaban and the latest updates from the manufacturers.

2. Interactive Discussions: Engage in case-based discussions to better understand real-world applications and prescribing challenges.

3. Evidence-Based Insights: Learn about the latest clinical trial data and the most current updates from global health organizations like ESC, AHA, and NICE.

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for the “Advancements in Anticoagulants: A Focus on Rivaroxaban” training, you consent to participate in this session hosted by CES on behalf of Tridem. Your registration will provide us with the necessary information to facilitate the event and issue CPD accreditation through the Medical and Dental Council (MDC). CES is committed to protecting your personal information and will not share any data with Novartis. Your data will only be shared with the relevant regulatory bodies, such as MDC, to ensure proper accreditation of CPD points.

Participants have the right to opt out of the session at any time. No further action is required if you choose to do so. We respect your privacy and ensure your participation remains confidential.

SPONSORED BY

This will be a virtual event. It will be streamed LIVE on this page.

Date: Wed, the 23rd July 2025

Time: 16:00 - 1830 GMT (4:00-6:30 pm Local Time)

Target Audience: General Practitioners (GPs)

The agenda is available to download in the downloads section.

Overview

Course Description

This virtual CPD training will provide healthcare professionals with an in-depth update on the latest advancements in anticoagulant therapy, focusing on Rivaroxaban’s clinical applications. The session will cover its evolving role in the treatment of conditions such as atrial fibrillation, pulmonary embolism, and surgical prophylaxis, supported by the most recent research findings. Participants will explore the pharmacology, clinical indications, and safety profile of Rivaroxaban, along with practical considerations for prescribing it, including dosing strategies and renal adjustments. The event will also feature expert-led discussions, case-based scenarios, and insights into emerging trends in anticoagulation therapy, equipping attendees with the knowledge to optimize patient care.

What you will learn

By the end of this training, participants will be able to:

1. Review the evolution of anticoagulant therapy, with a focus on the shift from VKAs to DOACs.

2. Explain the pharmacological profile of Rivaroxaban, including its mechanism of action and clinical indications.

3. Analyze recent clinical trial data supporting Rivaroxaban’s efficacy and safety across different patient populations.

4. Identify practical considerations when prescribing Rivaroxaban, such as dosing, renal adjustments, and managing bleeding risks.

5. Compare Rivaroxaban with other anticoagulants like warfarin and other DOACs, evaluating safety profiles and monitoring requirements.

6. Discuss emerging trends and future directions in anticoagulation therapy, including personalized medicine and the use of FXI inhibitors.

Course Content

Lecture Sessions

LIVE EVENT: Wed 23rd July 2025 @ 1630 GMT (4:00 pm) 1 hour 30 minutes

Downloadables

No downloadable content added to this course yet.

Steps to Join Course

1. Register or Login
2. Confirm your email address by clicking a link from your email
3. Choose course under your profession
4. Click on Get Free Course
5. Find your new course under My Courses
6. Click on course to see contents
7. Complete all Sessions and Quizes
8. Download your Certificate

About Facilitators

8 Courses on CES

Dr. Francis Agyekum

MBChB, FGCP, FWACP (Int. Med – Cardiol), Cert (Interv. Cardiol)

Interventional Cardiologist and Lecturer.

Korle-Bu Teaching Hospital, and the , School Of Medicine & Dentistry, College Of Health Sciences, University Of Ghana, Legon.

Dr. Francis Agyekum is a lecturer with the University of Ghana Medical School, College of Health Sciences, Legon. He is also a Consultant Cardiologist at the Korle-Bu Teaching Hospital. Dr.

View full profile / courses

7 Courses on CES

Prof. Jane Afriyie-Mensah

BSc, MBChB, FWACP

Consultant Pulmonologist/Physician Specialist

UGMS, Korle Bu Teaching Hospital

Prof. Jane Afriyie-Mensah is a distinguished Consultant Pulmonologist and Physician Specialist at Korle-Bu Teaching Hospital in Accra, Ghana. She is also affiliated with the University of Ghana and has significant expertise in both clinical practice and academic roles, specializing in respiratory and internal medicine. Prof.

View full profile / courses